nifekalant hydrochloride has been researched along with flecainide in 1 studies
| Studies (nifekalant hydrochloride) | Trials (nifekalant hydrochloride) | Recent Studies (post-2010) (nifekalant hydrochloride) | Studies (flecainide) | Trials (flecainide) | Recent Studies (post-2010) (flecainide) |
|---|---|---|---|---|---|
| 138 | 16 | 38 | 1,881 | 229 | 490 |
| Protein | Taxonomy | nifekalant hydrochloride (IC50) | flecainide (IC50) |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.8905 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 6.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanmatuse, K; Kojima, T; Kunimoto, S; Masaki, R; Nakai, T; Oshikawa, N; Ozawa, Y; Saito, S; Watanabe, H; Watanabe, I | 1 |
1 other study(ies) available for nifekalant hydrochloride and flecainide
| Article | Year |
|---|---|
Frequency-dependent electrophysiological effects of flecainide, nifekalant and d,l-sotalol on the human atrium.
Topics: Action Potentials; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Cohort Studies; Drug Evaluation; Electrophysiologic Techniques, Cardiac; Flecainide; Heart Atria; Humans; Middle Aged; Pyrimidinones; Sotalol | 2001 |